Literature DB >> 18454172

Negative regulation of multifunctional Ca2+/calmodulin-dependent protein kinases: physiological and pharmacological significance of protein phosphatases.

A Ishida1, N Sueyoshi, Y Shigeri, I Kameshita.   

Abstract

Multifunctional Ca2+/calmodulin-dependent protein kinases (CaMKs) play pivotal roles in intracellular Ca2+ signaling pathways. There is growing evidence that CaMKs are involved in the pathogenic mechanisms underlying various human diseases. In this review, we begin by briefly summarizing our knowledge of the involvement of CaMKs in the pathogenesis of various diseases suggested to be caused by the dysfunction/dysregulation or aberrant expression of CaMKs. It is widely known that the activities of CaMKs are strictly regulated by protein phosphorylation/dephosphorylation of specific phosphorylation sites. Since phosphorylation status is balanced by protein kinases and protein phosphatases, the mechanism of dephosphorylation/deactivation of CaMKs, corresponding to their 'switching off', is extremely important, as is the mechanism of phosphorylation/activation corresponding to their 'switching on'. Therefore, we focus on the regulation of multifunctional CaMKs by protein phosphatases. We summarize the current understanding of negative regulation of CaMKs by protein phosphatases. We also discuss the biochemical properties and physiological significance of a protein phosphatase that we designated as Ca2+/calmodulin-dependent protein kinase phosphatase (CaMKP), and those of its homologue CaMKP-N. Pharmacological applications of CaMKP inhibitors are also discussed. These compounds may be useful not only for exploring the physiological functions of CaMKP/CaMKP-N, but also as novel chemotherapies for various diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18454172      PMCID: PMC2439855          DOI: 10.1038/bjp.2008.127

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  96 in total

Review 1.  Neuronal Ca2+/calmodulin-dependent protein kinase II--discovery, progress in a quarter of a century, and perspective: implication for learning and memory.

Authors:  Takashi Yamauchi
Journal:  Biol Pharm Bull       Date:  2005-08       Impact factor: 2.233

Review 2.  Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy.

Authors:  Oswaldo Rodriguez-Mora; Michelle M LaHair; Christopher J Howe; James A McCubrey; Richard A Franklin
Journal:  Expert Opin Ther Targets       Date:  2005-08       Impact factor: 6.902

3.  Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme.

Authors:  Oren S Rosenberg; Sebastian Deindl; Rou-Jia Sung; Angus C Nairn; John Kuriyan
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

4.  Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis.

Authors:  Galina I Belova; Oleg N Demidov; Albert J Fornace; Dmitry V Bulavin
Journal:  Cancer Biol Ther       Date:  2005-10-23       Impact factor: 4.742

5.  Calmodulin kinase II inhibition protects against structural heart disease.

Authors:  Rong Zhang; Michelle S C Khoo; Yuejin Wu; Yingbo Yang; Chad E Grueter; Gemin Ni; Edward E Price; William Thiel; Silvia Guatimosim; Long-Sheng Song; Ernest C Madu; Anisha N Shah; Tatiana A Vishnivetskaya; James B Atkinson; Vsevolod V Gurevich; Guy Salama; W J Lederer; Roger J Colbran; Mark E Anderson
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

Review 6.  PP2C family members play key roles in regulation of cell survival and apoptosis.

Authors:  Shinri Tamura; Shinnosuke Toriumi; Jun-Ichi Saito; Kenjiro Awano; Tada-Aki Kudo; Takayasu Kobayashi
Journal:  Cancer Sci       Date:  2006-07       Impact factor: 6.716

Review 7.  Functional proteins involved in regulation of intracellular Ca(2+) for drug development: role of calcium/calmodulin-dependent protein kinases in ischemic neuronal death.

Authors:  Shigetoshi Yano; Motohiro Morioka; Jun-Ichi Kuratsu; Kohji Fukunaga
Journal:  J Pharmacol Sci       Date:  2005-03-12       Impact factor: 3.337

Review 8.  Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.

Authors:  Mark E Anderson
Journal:  Pharmacol Ther       Date:  2005-01-12       Impact factor: 12.310

9.  Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism.

Authors:  Abigail M Brown; Ariel Y Deutch; Roger J Colbran
Journal:  Eur J Neurosci       Date:  2005-07       Impact factor: 3.386

Review 10.  A role for calcium/calmodulin-dependent protein kinase II in cardiac disease and arrhythmia.

Authors:  T J Hund; Y Rudy
Journal:  Handb Exp Pharmacol       Date:  2006
View more
  9 in total

1.  Differential modulation of drug-induced structural and functional plasticity of dendritic spines.

Authors:  Eric C Miller; Lei Zhang; Benjamin W Dummer; Desmond R Cariveau; Horace Loh; Ping-Yee Law; Dezhi Liao
Journal:  Mol Pharmacol       Date:  2012-05-17       Impact factor: 4.436

2.  STK33 potentiates the malignancy of hypopharyngeal squamous carcinoma: Possible relation to calcium.

Authors:  Chen Chen; Lingyan Huang; Guodong Zhang; Yang Li; Li Li; Xiaohui Bai; Wenwen Liu; Haibo Wang; Jianfeng Li
Journal:  Cancer Biol Ther       Date:  2016-07-14       Impact factor: 4.742

3.  PPM1F controls integrin activity via a conserved phospho-switch.

Authors:  Tanja M Grimm; Nina I Dierdorf; Karin Betz; Christoph Paone; Christof R Hauck
Journal:  J Cell Biol       Date:  2020-12-07       Impact factor: 10.539

4.  Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways.

Authors:  Jenelle M Timmins; Lale Ozcan; Tracie A Seimon; Gang Li; Cristina Malagelada; Johannes Backs; Thea Backs; Rhonda Bassel-Duby; Eric N Olson; Mark E Anderson; Ira Tabas
Journal:  J Clin Invest       Date:  2009-09-08       Impact factor: 14.808

5.  Fast Decay of CaMKII FRET Sensor Signal in Spines after LTP Induction Is Not Due to Its Dephosphorylation.

Authors:  Nikolai Otmakhov; Shaurav Regmi; John E Lisman
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

6.  An active C-terminally truncated form of Ca (2+) /calmodulin-dependent protein kinase phosphatase-N (CaMKP-N/PPM1E).

Authors:  Atsuhiko Ishida; Kumiko Tsumura; Megu Oue; Yasuhiro Takenaka; Yasushi Shigeri; Naoki Goshima; Yasuhiro Ishihara; Tetsuo Hirano; Hiromi Baba; Noriyuki Sueyoshi; Isamu Kameshita; Takeshi Yamazaki
Journal:  Biomed Res Int       Date:  2013-08-07       Impact factor: 3.411

7.  Gender-specific potential inhibitory role of Ca2+/calmodulin dependent protein kinase phosphatase (CaMKP) in pressure-overloaded mouse heart.

Authors:  Miresta Prévilon; Mylène Pezet; Laurent Vinet; Jean-Jacques Mercadier; Patricia Rouet-Benzineb
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

8.  Meta-analysis identifies four new loci associated with testicular germ cell tumor.

Authors:  Charles C Chung; Peter A Kanetsky; Zhaoming Wang; Michelle A T Hildebrandt; Roelof Koster; Rolf I Skotheim; Christian P Kratz; Clare Turnbull; Victoria K Cortessis; Anne C Bakken; D Timothy Bishop; Michael B Cook; R Loren Erickson; Sophie D Fosså; Kevin B Jacobs; Larissa A Korde; Sigrid M Kraggerud; Ragnhild A Lothe; Jennifer T Loud; Nazneen Rahman; Eila C Skinner; Duncan C Thomas; Xifeng Wu; Meredith Yeager; Fredrick R Schumacher; Mark H Greene; Stephen M Schwartz; Katherine A McGlynn; Stephen J Chanock; Katherine L Nathanson
Journal:  Nat Genet       Date:  2013-05-12       Impact factor: 38.330

Review 9.  CaMKII-dependent responses to ischemia and reperfusion challenges in the heart.

Authors:  James R Bell; Martin Vila-Petroff; Lea M D Delbridge
Journal:  Front Pharmacol       Date:  2014-05-06       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.